To save researchers time and resources, The Michael J. Fox Foundation has made a number of tools available to the scientific community at low cost, with rapid delivery.
Helpful Resources
-
Sponsored Tools Program
Learn more about how MJFF can help share your tools.
-
Tools Consortium
MJFF is working with industry to develop priority tools.
-
Preclinical Models
Learn more about the various in vivo models used in Parkinson's disease research.
Find a Research Tool
Filter by Tool Type or Gene/Protein Type to Organize Results
* = MJFF does not control pricing or terms of availability for this tool.
Filters
Total Rab 10 Antibody
Antibody
Mouse monoclonal antibody directed against the human total Rab 10 protein. This antibody has been validated for immunoblotting experiments. This antibody epitope was mapped to amino acids 127-133.
Total PINK1 Antibody
Antibody
Monoclonal antibody directed against human total PINK1. Suitable for immunoblotting experiments. The antibody was mapped to AA 188-194 with some cross-reaction to AA287-301.
Total Parkin Antibody
Antibody
Monoclonal mouse antibody directed against human Parkin. Suitable for immunoblot experiments.
Total Parkin Antibody*
Antibody
Monoclonal mouse antibody directed against human Parkin. Suitable for immunoblot and immunohistochemistry experiments.
Total Parkin Antibody*
Antibody
Monoclonal mouse antibody directed against human Parkin. Suitable for immunohistochemistry applications, and evidence suggests this antibody may be binding to a conformational epitope.
Total DJ-1 Antibody
Antibody
Mouse monoclonal antibody directed against full length DJ-1. Ideal for use in immunoblotting or immunoassays.
TOMM20 Ubiquitinated at K56/61 Antibody
Antibody
Rabbit monoclonal antibody directed against the K56/61-ubiquitinated TOMM20.
Estimated Availability: Late 2025
TMEM192 Antibody
Antibody
Rabbit monoclonal antibody directed against human/mouse TMEM192 for immunoprecipitation of endogenous lysosomes.
Estimated Availability: Late 2025
TMEM175 Edited iPSC Lines
Human iPS Cell
KOLF2.1J human iPSC line with CRISPR-engineered mutations in TMEM175, including heterozygous and homozygous M393T mutations. These lines were generated within the iPSC Neurodegeneration Initiative for Parkinson’s Disease (iNDI-PD) which is supported by Aligning Science Across Parkinson's (ASAP). *Heterozygous and homozygous Q65P mutations are currently in development. Estimated Availability: Q1 2026.
TMEM175 Antibody
Antibody
Rabbit monoclonal antibody directed against human/mouse TMEM175 for immunoblotting and immunostaining applications.
Estimated Availability: Early 2025
Have questions or need additional information?
Email tools@michaeljfox.org with questions and to suggest new tools for us to develop. Or visit our FAQ page.
"We have shown, thanks in part to MJFF, that researchers now have in their pantry the right ‘ingredients’, to... help to drive forward PD drug development.”
Heather Melrose, PhD
Mayo Clinic